119 related articles for article (PubMed ID: 15569430)
1. [Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance].
Jiang WJ; Liu TH; Chen J; Gao J; Wu SF; Chen YJ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1705-9. PubMed ID: 15569430
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B
Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy.
Yang YM; Liu TH; Chen YJ; Jiang WJ; Qian JM; Lu X; Gao J; Wu SF; Sang XT; Chen J
Int J Cancer; 2005 Nov; 117(2):234-40. PubMed ID: 15900598
[TBL] [Abstract][Full Text] [Related]
4. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
Guo SS; Wu AY; Sawicki MP
World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
6. A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications.
Wild A; Langer P; Ramaswamy A; Chaloupka B; Bartsch DK
J Clin Endocrinol Metab; 2001 Dec; 86(12):5782-7. PubMed ID: 11739439
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT
Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours.
Nikiforova MN; Nikiforov YE; Biddinger P; Gnepp DR; Grosembacher LA; Wajchenberg BL; Fagin JA; Cohen RM
Clin Endocrinol (Oxf); 1999 Jul; 51(1):27-33. PubMed ID: 10468962
[TBL] [Abstract][Full Text] [Related]
10. Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis.
Jonkers YM; Claessen SM; Feuth T; van Kessel AG; Ramaekers FC; Veltman JA; Speel EJ
J Pathol; 2006 Dec; 210(4):450-8. PubMed ID: 17068744
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal instability predicts metastatic disease in patients with insulinomas.
Jonkers YM; Claessen SM; Perren A; Schmid S; Komminoth P; Verhofstad AA; Hofland LJ; de Krijger RR; Slootweg PJ; Ramaekers FC; Speel EJ
Endocr Relat Cancer; 2005 Jun; 12(2):435-47. PubMed ID: 15947114
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors.
Shan L; Nakamura Y; Nakamura M; Yokoi T; Tsujimoto M; Arima R; Kameya T; Kakudo K
Lab Invest; 1998 Apr; 78(4):471-5. PubMed ID: 9564891
[TBL] [Abstract][Full Text] [Related]
13. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas.
Hrasćan R; Pećina-Slaus N; Martić TN; Colić JF; Gall-Troselj K; Pavelić K; Karapandza N
J Neuroendocrinol; 2008 Aug; 20(8):1015-22. PubMed ID: 18510707
[TBL] [Abstract][Full Text] [Related]
14. [Refined deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal carcinoma].
Zheng HT; Tang HM; Peng ZH; Zhou CZ; He L
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):157-60. PubMed ID: 16555160
[TBL] [Abstract][Full Text] [Related]
15. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.
Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT
Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671
[TBL] [Abstract][Full Text] [Related]
16. Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors.
Ebrahimi SA; Wang EH; Wu A; Schreck RR; Passaro E; Sawicki MP
Cancer Res; 1999 Jan; 59(2):311-5. PubMed ID: 9927038
[TBL] [Abstract][Full Text] [Related]
17. Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas.
dos Reis PP; Poli-Frederico RC; dos Santos RM; Nishimoto IN; Kowalski LP; Rogatto SR
Med Sci Monit; 2002 Mar; 8(3):BR89-94. PubMed ID: 11889455
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma.
Zhou CZ; Peng ZH; Zhang F; Qiu GQ; He L
World J Gastroenterol; 2002 Aug; 8(4):668-73. PubMed ID: 12174376
[TBL] [Abstract][Full Text] [Related]
19. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia.
Anlauf M; Bauersfeld J; Raffel A; Koch CA; Henopp T; Alkatout I; Schmitt A; Weber A; Kruse ML; Braunstein S; Kaserer K; Brauckhoff M; Dralle H; Moch H; Heitz PU; Komminoth P; Knoefel WT; Perren A; Klöppel G
Am J Surg Pathol; 2009 Mar; 33(3):339-46. PubMed ID: 19011561
[TBL] [Abstract][Full Text] [Related]
20. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas.
Speel EJ; Scheidweiler AF; Zhao J; Matter C; Saremaslani P; Roth J; Heitz PU; Komminoth P
Cancer Res; 2001 Jul; 61(13):5186-92. PubMed ID: 11431358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]